Microphthalmia, seen in 19–39% of patients with CES2,3, was also seen with both presumptive null Cecr2 mutations on this background, but only associated with coloboma and at a lower penetrance than in humans (8.3–10%). This evidence concerns the gene CECR2 and microphthalmia.